399 related articles for article (PubMed ID: 28236310)
61. The SUPER study: protocol for a randomised controlled trial comparing follicle-stimulating hormone and clomiphene citrate for ovarian stimulation in intrauterine insemination.
Danhof NA; van Wely M; Koks CAM; Gianotten J; de Bruin JP; Cohlen BJ; van der Ham DP; Klijn NF; van Hooff MHA; Broekmans FJM; Fleischer K; Janssen CAH; Rijn van Weert JM; van Disseldorp J; Twisk M; Traas M; Verberg MFG; Pelinck MJ; Visser J; Perquin DAM; Boks DES; Verhoeve HR; van Heteren CF; Mol BWJ; Repping S; van der Veen F; Mochtar MH
BMJ Open; 2017 May; 7(5):e015680. PubMed ID: 28550023
[TBL] [Abstract][Full Text] [Related]
62. Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis.
Yu Y; Fang L; Zhang R; He J; Xiong Y; Guo X; Du Q; Huang Y; Sun Y
Sci Rep; 2017 Jun; 7(1):3812. PubMed ID: 28630466
[TBL] [Abstract][Full Text] [Related]
63. Endometrial thickness in women undergoing IUI with ovarian stimulation. How thick is too thin? A systematic review and meta-analysis.
Weiss NS; van Vliet MN; Limpens J; Hompes PGA; Lambalk CB; Mochtar MH; van der Veen F; Mol BWJ; van Wely M
Hum Reprod; 2017 May; 32(5):1009-1018. PubMed ID: 28333207
[TBL] [Abstract][Full Text] [Related]
64. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis.
Datta AK; Maheshwari A; Felix N; Campbell S; Nargund G
Hum Reprod Update; 2021 Feb; 27(2):229-253. PubMed ID: 33146690
[TBL] [Abstract][Full Text] [Related]
65. Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials.
Seko LM; Moroni RM; Leitao VM; Teixeira DM; Nastri CO; Martins WP
Fertil Steril; 2014 Jan; 101(1):154-161.e4. PubMed ID: 24182414
[TBL] [Abstract][Full Text] [Related]
66. Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial.
Liu Y; Chen Q; Yu S; Wang Y; He W; Chang HY; Wang B; Gao H; Long H; Wang L; Lyu Q; Ai A; Kuang Y
Clin Endocrinol (Oxf); 2018 Mar; 88(3):442-452. PubMed ID: 29247457
[TBL] [Abstract][Full Text] [Related]
67. Determining the optimal follicle size at trigger in patients undergoing ovarian stimulation with a clomiphene citrate plus gonadotropin and GnRH antagonist protocol for in-vitro fertilization.
Shah N; Romanski PA; Bortoletto P; Rosenwaks Z; Kligman I
Minerva Obstet Gynecol; 2022 Feb; 74(1):75-82. PubMed ID: 34180612
[TBL] [Abstract][Full Text] [Related]
68. Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics.
Diamond MP; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Ager J; Huang H; Hansen KR; Baker V; Usadi R; Seungdamrong A; Bates GW; Rosen RM; Haisonleder D; Krawetz SA; Barnhart K; Trussell JC; Jin Y; Santoro N; Eisenberg E; Zhang H;
Fertil Steril; 2015 Apr; 103(4):962-973.e4. PubMed ID: 25707331
[TBL] [Abstract][Full Text] [Related]
69. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
70. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels.
Tanbo T; Dale PO; Lunde O; Norman N; Abyholm T
Fertil Steril; 1992 Apr; 57(4):819-24. PubMed ID: 1555694
[TBL] [Abstract][Full Text] [Related]
71. Gonadotropin pulsatility in a stimulated cycle: clomiphene citrate increases pulse amplitudes of both luteinizing hormone and follicle-stimulating hormone.
Martikainen H; Rönnberg L; Ruokonen A; Kauppila A
Fertil Steril; 1991 Oct; 56(4):641-5. PubMed ID: 1915937
[TBL] [Abstract][Full Text] [Related]
72. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials.
Yang P; Wu R; Zhang H
Reprod Biol Endocrinol; 2020 Jul; 18(1):76. PubMed ID: 32727608
[TBL] [Abstract][Full Text] [Related]
73. Blastocyst vs cleavage-stage embryo transfer: systematic review and meta-analysis of reproductive outcomes.
Martins WP; Nastri CO; Rienzi L; van der Poel SZ; Gracia C; Racowsky C
Ultrasound Obstet Gynecol; 2017 May; 49(5):583-591. PubMed ID: 27731533
[TBL] [Abstract][Full Text] [Related]
74. Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial.
Leijdekkers JA; van Tilborg TC; Torrance HL; Oudshoorn SC; Brinkhuis EA; Koks CAM; Lambalk CB; de Bruin JP; Fleischer K; Mochtar MH; Kuchenbecker WKH; Laven JSE; Mol BWJ; Broekmans FJM; Eijkemans MJC;
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1332-1340. PubMed ID: 31127607
[TBL] [Abstract][Full Text] [Related]
75. Clomiphene citrate challenge test in the assessment of ovarian reserve before controlled ovarian hyperstimulation for intracytoplasmic sperm injection.
Kahraman S; Vicdan K; Işik AZ; Ozgün OD; Alaybeyoğlu L; Polat G; Biberoğlu K
Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):177-82. PubMed ID: 9228501
[TBL] [Abstract][Full Text] [Related]
76. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women.
Fisher SA; Reid RL; Van Vugt DA; Casper RF
Fertil Steril; 2002 Aug; 78(2):280-5. PubMed ID: 12137863
[TBL] [Abstract][Full Text] [Related]
77. Individualized follicle-stimulating hormone dosing and in vitro fertilization outcome in agonist downregulated cycles: a systematic review.
van Tilborg TC; Broekmans FJ; Dólleman M; Eijkemans MJ; Mol BW; Laven JS; Torrance HL
Acta Obstet Gynecol Scand; 2016 Dec; 95(12):1333-1344. PubMed ID: 27687487
[TBL] [Abstract][Full Text] [Related]
78. Letrozole versus clomiphene citrate for unexplained infertility: a systematic review and meta-analysis.
Liu A; Zheng C; Lang J; Chen W
J Obstet Gynaecol Res; 2014 May; 40(5):1205-16. PubMed ID: 24754848
[TBL] [Abstract][Full Text] [Related]
79. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin.
Tan SL; Maconochie N; Doyle P; Campbell S; Balen A; Bekir J; Brinsden P; Edwards RG; Jacobs HS
Am J Obstet Gynecol; 1994 Aug; 171(2):513-20. PubMed ID: 8059833
[TBL] [Abstract][Full Text] [Related]
80. A quality management approach to controlled ovarian stimulation in assisted reproductive technology: the "Fischer protocol".
Fischer R; Nakano FY; Roque M; Bento FC; Baukloh V; Esteves SC
Panminerva Med; 2019 Mar; 61(1):11-23. PubMed ID: 30674180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
